Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal-dominant variants in TGFBR1 underlie Loeys-Dietz syndrome 1 (LDS1). Heterozygous TGFBR1 mutations have been reported in at least six unrelated LDS1 probands, including de novo nonsense c.1237C>T (p.Arg413Ter) ([PMID:35181021]), recurrent de novo missense c.722C>T (p.Ser241Leu) ([PMID:16596670]), and additional kinase-domain substitutions c.1460G>A (p.Arg487Gln) ([PMID:17652900]) and c.1126A>G (p.Lys376Glu) ([PMID:30701076]).
Segregation analysis in a multigenerational family demonstrated co-segregation of the c.1043G>A (p.Cys348Tyr) variant with disease in an affected sibling (n=1) ([PMID:31475485]).
The TGFBR1 variant spectrum in LDS1 includes nonsense mutations (e.g., c.1237C>T (p.Arg413Ter)), missense substitutions within the serine/threonine kinase domain (e.g., c.688G>A (p.Ala230Thr); c.343+1G>C splice-donor disruption), and frameshift/truncating alleles (c.1342dup (p.Gln448ProfsTer15)) consistent with loss-of-function and dominant-negative effects.
Functional studies show that loss-of-function and dominant-negative TGFBR1 variants impair SMAD2/3 phosphorylation, activate paradoxical TGF-β signaling in patient aortic tissue, and induce contractile defects in hiPSC-derived smooth muscle cells that are rescued by activin A and rapamycin ([PMID:29706644]; [PMID:30701076]; [PMID:34346740]).
Mechanistically, TGFBR1 haploinsufficiency or dominant-negative disruption of the kinase domain perturbs canonical TGF-β signaling, leading to vascular aneurysm, skeletal dysplasia, and characteristic craniofacial features.
Given the variable prenatal and postnatal presentation, including untypical fetal skeletal findings, targeted sequencing of TGFBR1 is essential for definitive LDS1 diagnosis, risk stratification, and guiding aortic surveillance and potential therapeutic interventions.
Gene–Disease AssociationDefinitiveMultiple de novo and familial heterozygous TGFBR1 variants in ≥7 unrelated LDS1 probands, segregation in families, and concordant functional studies Genetic EvidenceStrongHeterozygous TGFBR1 variants identified in at least six unrelated probands, including three de novo nonsense/missense mutations ([PMID:35181021]; [PMID:16596670]; [PMID:17652900]) Functional EvidenceStrongKinase assays, ex vivo splicing, paradoxical signaling analyses, and hiPSC-derived smooth muscle cell models consistently demonstrate loss-of-function and dominant-negative TGFBR1 mechanisms ([PMID:29706644]; [PMID:30701076]; [PMID:34346740]) |